Ontology Development: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
Line 11: Line 11:
*[[Transcription |Transcription & transcription factor activity overhaul]] (Karen, David)
*[[Transcription |Transcription & transcription factor activity overhaul]] (Karen, David)
*[[Virus terms|Virus-related term overhaul]] (Michelle Gwinn Giglio, Jane Lomax, Candace Collmer, Ariane Toussaint, Brenley McIntosh, Alexander Diehl & others)
*[[Virus terms|Virus-related term overhaul]] (Michelle Gwinn Giglio, Jane Lomax, Candace Collmer, Ariane Toussaint, Brenley McIntosh, Alexander Diehl & others)
*[[Apoptosis]] (Paola, Becky, Pablo)
*[[Apoptosis]] (Emily, Becky, Paola, Pablo and community experts)


====Medium Priority====
====Medium Priority====

Revision as of 06:34, 2 November 2011

This group's purpose is to ensure that the Gene Ontology represents biology in a way that is useful for gene product annotation of reference genomes iphone photography and other MODs using the GO for annotation. The group serves as the link between biological knowledge that is gained from wet-bench scientists and the representation of that knowledge in the GO. Members of the group are responsible for reporting areas of the GO that need development and for suggesting changes and additions weight loss pills to the GO as needs arise. Members of the group serve as biological experts in domains that are covered by their organism. They are responsible for reviewing changes to be sure that they accurately reflect our current understanding of biology.

Content Development

Priority ranking

High Priority

Medium Priority

Low priority

Timeline

2010 Timeline

2011 Timeline

2012 Timeline

Proposed content work

A list of topics that we propose to address, but for which a timeline has not been set

Completed ontology content work

Other Ontology Development Group Activities

Editor's Conference calls-weekly 7-7.30 AM PST

Administrative